James T. Rosenbaum

From Wikipedia, the free encyclopedia

James T. Rosenbaum (born September 29, 1949) is an American physician-scientist who is Senior Vice President for Research at Corvus Pharmaceuticals[1] and Chief of Ophthalmology emeritus at the Legacy Devers Eye Institute, Portland, Oregon, where he held the Richard Chenoweth Chair.[2] Previously, he was Chief of Arthritis and Rheumatic Diseases at the Oregon Health & Science University where he held the Edward E Rosenbaum Professorship in Inflammation Research.[3] Rosenbaum was the only practicing rheumatologist/non-ophthalmologist in the world to serve as a chief of ophthalmology. He is recognized for his description of an animal model of uveitis (inflammation inside the eye) resulting from injection of bacterial endotoxin (Nature, 286:611, 1980) and for more than 600 scholarly publications, mostly related to the intersection between rheumatology and ophthalmology.[4] He is a co-author of the book, "The Clinical Neurology of Rheumatic Diseases".[5]

Education[edit]

Rosenbaum is a National Merit Scholar who graduated from Harvard College in 1971, magna cum laude. He graduated from Yale Medical School with honors in 1975.[4] He did an internship and residency in internal medicine at Stanford Medical Center from 1975 to 1978. He was a fellow of the Arthritis Foundation under the supervision of Hugh O. McDevitt at Stanford from 1978 to 1981.[6]

Family[edit]

Rosenbaum is part of a notable family that includes ten physicians including his father, Edward E Rosenbaum, author of "A Taste of My Own Medicine: When the Doctor Is the Patient".[7] His maternal grandmother was Rose Naftalin.

Honors[edit]

Rosenbaum is an elected member of the American Society of Clinical Investigation and the Association of American Physicians. He was given a lifetime achievement award from the American Academy of Ophthalmology. He was awarded the Friedenwald Award from the Association for Research in Vision and Ophthalmology in 2011,[6] the Gold Medal from the International Uveitis Study Group Eye Foundation in 2012,[8] the Cless Award from the University of Illinois, Chicago in 2012,[9] and the American College of Rheumatology Distinguished Clinician Scholar Award in 2013.[10] His first authored papers or essays have appeared in journals that include Science,[11] Nature,[12] the New England Journal of Medicine,[13] JAMA,[14][15] Annals of Internal Medicine,[16] the Archives of Internal Medicine[17] and the online source for physicians, UpToDate.

References[edit]

  1. ^ "Leadership". Corvus Pharmaceuticals. Retrieved 2023-05-14.
  2. ^ "James T. Rosenbaum MD". Legacyhealth.org. Retrieved 2013-11-06.
  3. ^ "James T. Rosenbaum, M.D. | Arthritis & Rheumatic Diseases (Adult) | OHSU". Ohsu.edu. Archived from the original on 2013-11-07. Retrieved 2013-11-06.
  4. ^ a b Nature Reviews Rheumatology (May 2012). "About the authors : Spondyloarthritis: The eyes have it: uveitis in patients with spondyloarthritis : Nature Reviews Rheumatology". Nature Reviews Rheumatology. 8 (5). Nature.com: 249–250. doi:10.1038/nrrheum.2012.43. PMC 3343203. PMID 22469907.
  5. ^ Lahita, Robert G. (1997). "Book Review Clinical Neurology of Rheumatic Diseases by Richard B. Rosenbaum, Stephen M. Campbell, and James T. Rosenbaum. 436 pp. Illustrated. Boston, Butterworth–Heinemann, 1996. $95. 0-7506-9613-3". New England Journal of Medicine. 336 (19): 1397. doi:10.1056/NEJM199705083361922.
  6. ^ a b Friederike Mackensen (2011-09-28). "Introducing James T. Rosenbaum, the 2011 Recipient of the Friedenwald Award". Iovs.org. Retrieved 2013-11-06.
  7. ^ Steve Beaven; The Oregonian (June 2009). "Prominent Portland doctor and author dies". OregonLive.com. Retrieved 2013-11-06.
  8. ^ 8th International Symposium on Uveitis (PDF), International Uveitis Study Group, 2012, p. 7, archived from the original (PDF) on 2014-05-12
  9. ^ "Donor Events - University of Illinois College of Medicine a". Chicago.medicine.uic.edu. 2012-10-05. Retrieved 2013-11-06.
  10. ^ "Awards of Distinction and Masters | American College of Rheumatology | ACR". Rheumatology.org. Retrieved 2013-11-06.
  11. ^ Rosenbaum, JT (1997). "Lessons from litigation over silicone breast implants: A call for activism by scientists". Science. 276 (5318): 1524–5. doi:10.1126/science.276.5318.1524. PMID 9190690.
  12. ^ Rosenbaum, JT; McDevitt, HO; Guss, RB; Egbert, PR (1980). "Endotoxin-induced uveitis in rats as a model for human disease". Nature. 286 (5773): 611–3. Bibcode:1980Natur.286..611R. doi:10.1038/286611a0. PMID 7402339. S2CID 4362456.
  13. ^ Rosenbaum, James T. (2012). "Eyeing Macular Degeneration — A Few Inflammatory Remarks". New England Journal of Medicine. 367 (8): 768–70. doi:10.1056/NEJMcibr1204973. PMID 22913688.
  14. ^ Rosenbaum, James T. (2009). "Howard". JAMA. 302 (9): 929–30. doi:10.1001/jama.2009.1170. PMID 19724031.
  15. ^ Rosenbaum, James T. (2008). "In Defense of Phobias". JAMA. 299 (20): 2368. doi:10.1001/jama.299.20.2368. PMID 18505937.
  16. ^ Rosenbaum, JT (1981). "Why HLA-B27: An analysis based on two animal models". Annals of Internal Medicine. 94 (2): 261–3. doi:10.7326/0003-4819-94-2-261. PMID 6937155.
  17. ^ Rosenbaum, JT (1989). "Uveitis. An internist's view". Archives of Internal Medicine. 149 (5): 1173–6. doi:10.1001/archinte.149.5.1173. PMID 2719509.
Retrieved from "https://en.wikipedia.org/w/index.php?title=James_T._Rosenbaum&oldid=1155378868"